|
Neal Dickert, MD, PhD, is currently a house officer in the Department of Medicine at the Johns Hopkins Hospital. In 2006, Neal received his medical degree from the Johns Hopkins School of Medicine and his doctorate from the program in Bioethics and Health Policy at the Bloomberg School of Public Health. His doctoral dissertation, "Maintaining respect at the margins of agency: respect for persons and research in emergency settings," focused on understanding the meaning and demands of the principle of respect for persons when doing research with participants who have diminished or absent capacity for rational agency. In particular, Neal concentrated on the challenges of conducting research in emergency settings when informed consent is not practicable. Prior to coming to Hopkins, Neal graduated from Dartmouth College in 1997 with a Bachelor's degree in Philosophy and completed a two-year pre-doctoral fellowship in the NIH Department of Clinical Bioethics. In addition to his dissertation work, Neal is interested in and has published work on offering incentives to participants in clinical research, the process of community consultation for clinical research, consent requirements for cadaveric organ procurement, and ethical issues arising in the conduct of research in the developing world. After residency in internal medicine, Neal will start a fellowship in cardiology at Emory University and plans to develop an academic career investigating important ethical and policy issues arising in clinical and academic cardiology.
Summer Johnson, PhD, completed her PhD in Bioethics and Health Policy at the Johns Hopkins School of Public Health in Fall 2006. While at Johns Hopkins, Dr. Johnson worked as a graduate research and teaching assistant for the Berman Institute of Bioethics. As student, Summer was awarded the 2005 Marcia Pines Award in Bioethics and Health Policy. Before attending Johns Hopkins, Summer was awarded a Fulbright Scholarship (declined) to study ethical issues in stem cell research in Canada. Dr. Johnson is a Phi Beta Kappa, Summa Cum Laude graduate of Indiana University, where she completed a double major in philosophy and bioethics.Summer is currently an assistant professor of medicine at the Alden March Bioethics Institute (AMBI) in Albany, New York. She is the Director of Graduate Studies at AMBI where she runs an online Masters of Science degree in Bioethics as well as a Certificate Program in Clinical Ethics. Dr. Johnson is also is the Director of the Ethics in Novel Technologies, Research, and Innovation (ENTRI) Program, a research program focusing on ethical issues in innovative technologies as they are applied to health, in particular ethical issues in nanomedicine.
Ingrid Burger, MD, PhD received her medical degree from the Johns Hopkins School of Medicine and her doctorate from the program in Bioethics and Health Policy at the Bloomberg School of Public Health in May 2007. Her clinical interests are in diagnostic and interventional radiology and her research interests involve ethics and policy issues concerning the emergence and diffusion of medical technology. Her dissertation work focused on ethics and policy issues related to direct-to-consumer marketing of CT screening services to the public. She is currently interning at Memorial Sloan Kettering Cancer Center in New York, and will begin radiology residency training at the University of California, San Francisco in July, 2008.
Sara Chandros Hull, PhD received her undergraduate degree in molecular cell biology and genetics at Brandeis University. Since completing her graduate training at Johns Hopkins (PhD in the Program in Law, Ethics and Health) in 1999, Dr. Hull has been employed by the National Human Genome Research Institute (NHGRI) at NIH, with responsibility for a variety of bioethics-related service, research, and training initiatives. She currently is director of the NHGRI Bioethics Core, which provides support and training to the NHGRI intramural research program. In addition, she is a faculty member in the NIH Department of Clinical Bioethics, and is an adjunct assistant professor in the Johns Hopkins Bloomberg Schoool of Public Health, Department of Health, Behavior, and Society. Dr. Hull is an attending consultant with the NIH Ethics Consult Service and serves as Associate Chair of the NHGRI IRB. Dr. Hull's research has focused on a broad range of issues in genetics and genetic research, including informed consent for use of tissue specimens, recruitment of family members in research, and direct-to-consumer advertising of genetic testing. In addition, she has collaborated on several bioethics-related projects that employed qualitative research methodology in such areas as researcher conflicts-of-interest, priority-setting decisions by physicians, and the design of health-related employee benefits packages.
Andrea Kalfoglou, PhD is an Assistant Professor in the Sociology/Anthropology Department at the University of Maryland, Baltimore County (UMBC) where she teaches courses for the Health Administration and Policy Program. Previously, she completed a Research Fellowship in the Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health where she conducted empirical research to study the social, ethical, and political, effects of the Human Genome Project. She has also worked for the Genetics and Public Policy Center at Johns Hopkins University, the Institute of Medicine, the National Bioethics Advisory Committee under the Clinton Administration, and the National Board on Ethics and Reproduction (NABER). She has extensive experience in ethical and health-policy analysis related to human reproduction, genetics, and research ethics. Her previous empirical research includes public attitudes about the appropriate uses of reproductive genetic technology, and the experiences and attitudes of both PGD users and oocyte donors. She is on the Editorial Board of the American Journal of Bioethics, Board of Advisors for the Center for Information and Study of Clinical Research Participation, and Chair of the bioethics subcommittee of the Greek Orthodox Archdiocesan Advisory Committee on Science and Technology. She holds a Ph.D. in Health Policy and Management from the Johns Hopkins Bloomberg School of Public Health and a B.A. in Political and Social Thought from the University of Virginia.
Julia Slutsman, PhD, is a Health Science Policy Analyst at the Office for Human Subjects Research at the National Institutes of Health
(NIH). She is involved in regulation and policy development for the Human Research Protections Program at NIH and also conducts research on a number of topics related to the protection of research subjects. Dr. Slutsman also serves as an adjunct Assistant Professor in the Department of Preventive Medicine and Biometrics at the Uniformed Services University of the Health. Dr. Slutsman holds a doctorate degree in Health Policy and Management with a concentration in bioethics from the Johns Hopkins University Bloomberg School of Public Health. Her dissertation research focused on the privacy practices of physicians and health care organizations. After obtaining her degree, completed the Cancer Prevention Post-doctoral Fellowship at the National Cancer Institute, NIH where she studied risk/benefit determination and other ethical issues arising in the context of enrollment of healthy and at-risk populations into cancer prevention trials.
Jane Forman, ScD MHS, earned her ScD from the Program in Law, Ethics, and Health (2001) and an MHS in Health Finance and Management (1991), both at the Johns Hopkins Bloomberg School of Public Health. Her undergraduate training was at Harvard College, where she earned an A.B. degree in 1985. Dr. Forman is a Research Scientist and Director of Qualitative Research at the Department of Veterans Affairs Ann Arbor Center for Practice Management and Outcomes Research. At the VA, she collaborates with and mentors investigators in the design, data collection, and analysis phases of studies that include qualitative research methods. These studies include: understanding how patients with incurable, progressive illness are cared for within primary care and oncology, and the factors that foster or hinder the provision of effective palliative care; analyzing communication about diabetes self-management in visits between patients and their primary care physicians; identifying factors that facilitate and impede the adoption of evidence-based infection prevention practices in hospitals; and evaluating an intervention to improve antipsychotic medication adherence among patients with serious mental illness. Dr. Forman teaches qualitative methods to investigators in the Robert Wood Johnson Clinical Scholars Program at the University of Michigan Medical School. As part of the Program in Bioethics at the University of Michigan, Dr. Forman is a co-investigator on NIH-funded project that is developing, implementing and evaluating a course designed to improve the knowledge and skills of investigators for obtaining valid consent from potential research volunteers. Dr. Forman is a member of the ethics committee at St. Joseph Mercy Hospital in Ann Arbor, where, as a volunteer, she is leading a project to improve communication about goals of care between the medical team and families of critically ill patients. She is the author of a chapter on Qualitative Content Analysis in an upcoming book on empirical research methods in bioethics to be published by Elsevier.
Holly A. Taylor, MPH, PhD
|
